Literature DB >> 21521506

Frequency distribution of HCV genotypes among chronic hepatitis C patients of Khyber Pakhtunkhwa.

Sajid Ali1, Ijaz Ali, Sadiq Azam, Bashir Ahmad.   

Abstract

BACKGROUND: Hepatitis C Virus (HCV) genotypes frequency is important for the predication of response to therapy and duration of treatment. Despite variable response rates experienced in the case of Interferon (IFN) -based therapies, there was scarcity of data on HCV genotypes frequency in Khyber Pakhtunkhwa (KPK). STUDY
DESIGN: A total of 200 blood samples were collected from chronic HCV patients prior to the initiation of anti-viral therapy. The study population included patients from 6 districts of KPK. Active HCV infection was confirmed in case of all the patients by real time PCR. HCV genotypes were determined in each case by Type-specific PCR.
RESULTS: The analysis revealed that out of 200 PCR positive samples; 78 (39%) were 2a, 62 (31%) were 3a, 16 (8%) were 3b, 34 (17%) were untypable while 1a, 2b and 1b were 3 (1.5%), 2 (1%) and 5 (2.5%), respectively.
CONCLUSION: Genotype determination is not carried out prior to therapy in KPK. Although, the abundantly prevalent types (2a and 3a) of HCV in KPK are susceptible to combination therapy, yet resistance experienced in some of the chronic HCV patients may partly be attributed to the prevalence of less prevalent resistant genotypes (1a, 1b) of HCV among the population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521506      PMCID: PMC3113302          DOI: 10.1186/1743-422X-8-193

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  24 in total

1.  Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma.

Authors:  T A Cha; J Kolberg; B Irvine; M Stempien; E Beall; M Yano; Q L Choo; M Houghton; G Kuo; J H Han
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Authors:  G Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

3.  Differences in the hepatitis C virus genotypes in different countries.

Authors:  N Takada; S Takase; A Takada; T Date
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

4.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

5.  Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group.

Authors:  H Tokita; S M Shrestha; H Okamoto; M Sakamoto; M Horikita; H Iizuka; S Shrestha; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1994-04       Impact factor: 3.891

6.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

7.  Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.

Authors:  J B Nousbaum; S Pol; B Nalpas; P Landais; P Berthelot; C Bréchot
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

8.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

Authors:  G L Davis; R Esteban-Mur; V Rustgi; J Hoefs; S C Gordon; C Trepo; M L Shiffman; S Zeuzem; A Craxi; M H Ling; J Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

10.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

View more
  13 in total

1.  Diagnostically untypable hepatitis C virus variants: it is time to resolve the problem.

Authors:  Muhammad Sohail Afzal; Muhammad Yousaf Khan; Muhammad Ammar; Sadia Anjum; Najm Us Sahar Sadaf Zaidi
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  Molecular study of HCV detection, genotypes and their routes of transmission in North West Frontier Province, Pakistan.

Authors:  Sher Zaman Safi; Yasir Waheed; Joharia Sadat; Sadia Salahuddin; Umar Saeed; Muhammad Ashraf
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

Review 3.  Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.

Authors:  Muhammad Umer; Mazhar Iqbal
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 4.  Hepatitis C virus genotypes in Pakistan: a systemic review.

Authors:  Sobia Attaullah; Sanaullah Khan; Ijaz Ali
Journal:  Virol J       Date:  2011-09-08       Impact factor: 4.099

5.  Distribution and predominance of genotype 3 in hepatitis C virus carriers in the province of kahramanmaras, Turkey.

Authors:  Ahmet Caliskan; Ozlem Kirisci; Esra Ozkaya; Sevinc Ozden; Seray Tumer; Serkan Caglar; Selma Ates Guler; Hande Senol
Journal:  Hepat Mon       Date:  2015-04-25       Impact factor: 0.660

Review 6.  Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis.

Authors:  Farzin Sadeghi; Mostafa Salehi-Vaziri; Amir Almasi-Hashiani; Mohammad Gholami-Fesharaki; Reza Pakzad; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-04-19       Impact factor: 0.660

7.  Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants.

Authors:  Linda Dunford; Michael J Carr; Jonathan Dean; Allison Waters; Linh Thuy Nguyen; Thu Hong Ta Thi; Lan Anh Bui Thi; Huy Duong Do; Thu Thuy Duong Thi; Ha Thu Nguyen; Trinh Thi Diem Do; Quynh Phuong Luu; Jeff Connell; Suzie Coughlan; Hien Tran Nguyen; William W Hall; Lan Anh Nguyen Thi
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

8.  Prevalence of hepatitis C virus genotypes in district bannu, khyber pakhtunkhwa, pakistan.

Authors:  Shamim Saleha; Anwar Kamal; Farman Ullah; Nasar Khan; Asif Mahmood; Sanaullah Khan
Journal:  Hepat Res Treat       Date:  2014-06-30

9.  Molecular characterization of Hepatitis C virus 3a in Peshawar.

Authors:  Amina Gul; Nabeela Zahid; Jawad Ahmed; Fazli Zahir; Imtiaz Ali Khan; Ijaz Ali
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

10.  Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0.

Authors:  Alex M Dussaq; Abha Soni; Christopher Willey; Seung L Park; Shuko Harada
Journal:  J Pathol Inform       Date:  2017-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.